225. Congenital nephrogenic diabetes insipidus Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 19 /  Drugs : 56 - (DrugBank : 21) / Drug target genes : 33 - Drug target pathways : 67

Congenital nephrogenic diabetes insipidus and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)